Sign in
4

Changes in Ownership

Jazz Pharmaceuticals plc Filed Acc 0001765581-20-000109

Director sold 12,500 shares at an average $153.44 ($1,918,000)

  • Director acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sohn Catherine A. · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-04 Exercise or conversion : show line 1 in the form +4,500 $81.76 $367,920 15,122 D
2020-11-04 Sale : show line 2 in the form −4,500 $156.00 $702,000 10,622 D
2020-11-04 Exercise or conversion : show line 3 in the form +8,000 $46.83 $374,640 18,622 D
2020-11-04 Sale : show line 4 in the form −8,000 $152.00 $1,216,000 10,622 D
Open-market sales · 12,500 sh · avg $153.44 · $1,918,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-11-04 Exercise or conversion : show line 5 in the form Non-Qualified Stock Option (right to buy) −8,000 0 D
2020-11-04 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) −4,500 0 D
Loading xslF345X03/edgardoc.xml…